Atom Investors LP Iovance Biotherapeutics, Inc. Transaction History

Atom Investors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $133,448 - $270,248	-8,172 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $15,510 - $28,451	541 Added 7.09%	8,172 $259,000
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $213,973 - $383,534	7,631 New	7,631 $354,000
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $1.53 Million - $3.04 Million	-78,146 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$17.95 - $29.41 $261,495 - $428,444	-14,568 Reduced 15.71%	78,146 $2.16 Million
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $2.58 Million - $3.73 Million	-143,622 Reduced 60.77%	92,714 $1.69 Million
Q2 2019 Aug 14, 2019	BUY	$9.78 - $24.52 $2.31 Million - $5.79 Million	236,336 New	236,336 $5.8 Million

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.